Connect Biopharma Holdings Limited (CNTB)

NASDAQ: CNTB · Real-Time Price · USD

0.7610

-0.0414 (-5.16%)

At close: May 13, 2025, 4:00 PM

0.8298

+0.0688 (9.04%)

Pre-market: May 14, 2025, 9:01 AM EDT

CNTB Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	2018 - 2019
Revenue	26.03	-	-	-	-	Upgrade
Gross Profit	26.03	-	-	-	-	Upgrade
Selling, General & Admin	19.23	16.05	20.81	19.01	7.31	Upgrade
Research & Development	29.26	53	96.63	80.5	23.12	Upgrade
Other Operating Expenses	-	-	-1.08	-1.85	-1.07	Upgrade
Operating Expenses	48.49	69.06	116.36	97.66	29.36	Upgrade
Operating Income	-22.45	-69.06	-116.36	-97.66	-29.36	Upgrade
Interest Expense	-	-	-0.02	-0.01	-0.44	Upgrade
Interest & Investment Income	4.45	5.22	1.81	0.17	0.21	Upgrade
Currency Exchange Gain (Loss)	-	-	1.47	-0.52	-1.04	Upgrade
Other Non Operating Income (Expenses)	2.59	1.85	-	-103.98	-88.73	Upgrade
EBT Excluding Unusual Items	-15.41	-61.99	-113.1	-202	-119.36	Upgrade
Asset Writedown	-	-	-4.7	-	-	Upgrade
Pretax Income	-15.41	-61.99	-117.79	-202	-119.36	Upgrade
Income Tax Expense	0.22	0.12	0.3	0.27	-	Upgrade
Earnings From Continuing Operations	-15.63	-62.11	-118.09	-202.27	-119.36	Upgrade
Net Income	-15.63	-62.11	-118.09	-202.27	-119.36	Upgrade
Net Income to Common	-15.63	-62.11	-118.09	-202.27	-119.36	Upgrade
Shares Outstanding (Basic)	55	55	55	52	17	Upgrade
Shares Outstanding (Diluted)	55	55	55	52	17	Upgrade
Shares Change (YoY)	0.27%	0.04%	5.50%	205.31%	1.27%	Upgrade
EPS (Basic)	-0.28	-1.13	-2.15	-3.88	-6.98	Upgrade
EPS (Diluted)	-0.28	-1.13	-2.15	-3.88	-6.98	Upgrade
Free Cash Flow	-24.36	-47.82	-105.93	-88.16	-27.9	Upgrade
Free Cash Flow Per Share	-0.44	-0.87	-1.92	-1.69	-1.63	Upgrade
Gross Margin	100.00%	-	-	-	-	Upgrade
Operating Margin	-86.24%	-	-	-	-	Upgrade
Profit Margin	-60.03%	-	-	-	-	Upgrade
Free Cash Flow Margin	-93.58%	-	-	-	-	Upgrade
EBITDA	-21.79	-68.34	-115.63	-97.17	-29.21	Upgrade
EBITDA Margin	-83.71%	-	-	-	-	Upgrade
D&A For EBITDA	0.66	0.72	0.73	0.49	0.15	Upgrade
EBIT	-22.45	-69.06	-116.36	-97.66	-29.36	Upgrade
EBIT Margin	-86.24%	-	-	-	-	Upgrade
Revenue as Reported	26.03	-	-	-	-	Upgrade

Updated Sep 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q